SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2

Simcere Pharmaceutical Group

(Name of Issuer)

Ordinary Shares, par value US$0.01 per share

(Title of Class of Securities)

82859P 10 4 ¹

(CUSIP Number)

December 31, 2010

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o     Rule 13d-1(b)
o     Rule 13d-1(c)
þ     Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No.		82859P 10 4

CUSIP No.		82859P 10 4	13G

Item 1(a).		Name of Issuer:

Simcere Pharmaceutical Group (the “Issuer”)

Item 1(b).		Address of Issuer’s Principal Executive Offices:

No.699-18 Xuan Wu Avenue Xuan Wu District, Nanjing Jiangsu Province 210042 The People’s Republic of China

Item 2(a).		Name of Person Filing:

New Good Management Limited

Item 2(b).		Address of Principal Business Office, or, if None, Residence:

No.699-18 Xuan Wu Avenue Xuan Wu District, Nanjing Jiangsu Province 210042 The People’s Republic of China

Item 2(c).		Citizenship or Place of Organization:

British Virgin Islands

Item 2(d).		Title of Class of Securities:

Ordinary Shares

Item 2(e).		CUSIP Number:

82859P 10 4

Item 3.		If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

Item 4.		Ownership.

The following information with respect to the ownership of the Ordinary Shares of the Issuer by the person filing this statement is provided as of December 31, 2010. The percentage amount is based

on 107,884,546 Ordinary Shares outstanding as of December 31, 2010, as derived from the Issuer’s corporate records.

Number of shares as to which the person has:

Sole power

Shared

Sole

Shared

to dispose

power to

power to

power to

or to

dispose or

Amount

vote or

vote or to

direct the

to direct the

Reporting

beneficially

Percent

to direct

direct

disposition

disposition

Person

owned:

of class:

the vote:

the vote:

of:

of:

New Good Management Limited

40,599,160

37.6

%

—

40,599,160

—

40,599,160

New Good Management Limited (“NGM”) is the record holder of 40,599,160 Ordinary Shares of the Issuer. Prior to May 2008, NGM did not have any controlling shareholder. In May 2008, Mr. Jinsheng Ren, the Chairman of the Board of Directors of NGM (“Mr. Ren”), became a controlling shareholder of NGM. Pursuant to Rule 13d-3 under the Act, Mr. Ren may be deemed to share with NGM the voting and dispositive power over the 40,599,160 Ordinary Shares held by NGM.

Item 5.		Ownership of Five Percent or Less of a Class.

Not applicable

Item 6.		Ownership of More Than Five Percent on Behalf of Another Person.

Not applicable

Item 7.		Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not applicable

Item 8.		Identification and Classification of Members of the Group.

Not applicable

Item 9.		Notice of Dissolution of Group.

Not applicable

Item 10.		Certifications.

Not applicable

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 11, 2011